<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-14T20:37:49+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2676】少见突变晚期NSCLC接受免疫治疗的疗效和安全性如何？</title>
    <updated>2020-12-14T19:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/6H46Gno41VW0GX_T4vBkZQ</id>
    <link href="https://mp.weixin.qq.com/s/6H46Gno41VW0GX_T4vBkZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020肺癌多学科治疗高峰论坛：名家云集共襄盛举，RET靶点曙光将至</title>
    <updated>2020-12-14T19:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/XK0mC1tFp2deBCOATPpbRg</id>
    <link href="https://mp.weixin.qq.com/s/XK0mC1tFp2deBCOATPpbRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中山医院葛均波院士团队“肿瘤心脏病学”创新成果落地 ，“小程序”成为肿瘤患者护“心”法宝</title>
    <updated>2020-12-14T19:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/KlzAUbysAvIkpPBEwoIjQQ</id>
    <link href="https://mp.weixin.qq.com/s/KlzAUbysAvIkpPBEwoIjQQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【中肿食管癌单病种团队】这群医生的研究被赞“里程碑”</title>
    <updated>2020-12-14T19:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/UMzlHHJn8AJ3ufD18gLXOA</id>
    <link href="https://mp.weixin.qq.com/s/UMzlHHJn8AJ3ufD18gLXOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020 SABCS】袁芃教授点评医肿乳腺团队重磅内容，唱响“中国好声音”</title>
    <updated>2020-12-14T19:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/KbPWTzvW1ePGLIhcv9iEzA</id>
    <link href="https://mp.weixin.qq.com/s/KbPWTzvW1ePGLIhcv9iEzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>紫杉醇脂质体联合顺铂对比吉西他滨联合顺铂一线治疗晚期肺鳞癌：疗效相当，安全性和依从性更优</title>
    <updated>2020-12-14T19:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/dZjRo2dilsAfv8ACjv_QgQ</id>
    <link href="https://mp.weixin.qq.com/s/dZjRo2dilsAfv8ACjv_QgQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>快讯 | 氟唑帕利正式获批，卵巢癌迎来首个国产PARP抑制剂</title>
    <updated>2020-12-14T19:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/x8l4HRCl4cj9Us7tMTKHcg</id>
    <link href="https://mp.weixin.qq.com/s/x8l4HRCl4cj9Us7tMTKHcg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2675】|2020 SABCS| 袁芃教授：用同源重组缺陷评分预测中国三阴性乳腺癌患者特征和结局</title>
    <updated>2020-12-13T20:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/37nkoh8jLndvMSC1yazpvQ</id>
    <link href="https://mp.weixin.qq.com/s/37nkoh8jLndvMSC1yazpvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【NEJM】KEYNOTE-177全文发表，MSI-H/dMMR晚期结直肠癌一线免疫治疗带给我们哪些启示？</title>
    <updated>2020-12-13T20:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/See8CFDeAh2p93sfvoSjrw</id>
    <link href="https://mp.weixin.qq.com/s/See8CFDeAh2p93sfvoSjrw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>黄镜教授谈晚期食管癌免疫治疗的进展与挑战</title>
    <updated>2020-12-13T20:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/ZFRlFXVOolVozHOKX3uH-A</id>
    <link href="https://mp.weixin.qq.com/s/ZFRlFXVOolVozHOKX3uH-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同样是肺癌，但这类患者中却有超过10%的人可能会发生第二原发恶性肿瘤</title>
    <updated>2020-12-13T20:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/mQ1CqU5Pkm_-PJVGaNOVlQ</id>
    <link href="https://mp.weixin.qq.com/s/mQ1CqU5Pkm_-PJVGaNOVlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【中国好声音】JAMA | 中肿十年攀高峰，SYSUCC-001研究为三阴性乳腺癌维持治疗给出漂亮答案！</title>
    <updated>2020-12-12T19:12:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/-wBmfnIbvdXnTGAfwClUEA</id>
    <link href="https://mp.weixin.qq.com/s/-wBmfnIbvdXnTGAfwClUEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浸润性肺腺癌组织学分级新进展</title>
    <updated>2020-12-12T19:12:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/R8AsgVsQrGIm7vorroHIpg</id>
    <link href="https://mp.weixin.qq.com/s/R8AsgVsQrGIm7vorroHIpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>至精至微 至诚至善丨艺匠TOP 100中国结直肠肿瘤精英论坛——重庆站会议菁彩回顾</title>
    <updated>2020-12-12T19:12:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/eFHjrgzrHkMqza3B7eVpZw</id>
    <link href="https://mp.weixin.qq.com/s/eFHjrgzrHkMqza3B7eVpZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020 SABCS】HER2阳性乳腺癌多项重磅研究详细数据来袭，邀您一睹为快</title>
    <updated>2020-12-12T19:12:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/40sBDkWXAPprhtA9Fw-n7A</id>
    <link href="https://mp.weixin.qq.com/s/40sBDkWXAPprhtA9Fw-n7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2673】2020 SABCS乳腺癌前沿进展大赏</title>
    <updated>2020-12-11T19:40:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/kSIaRhq6UzU_EJk2u10u2g</id>
    <link href="https://mp.weixin.qq.com/s/kSIaRhq6UzU_EJk2u10u2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>帕博利珠单抗获批头颈鳞癌一线治疗适应症，郭晔教授开出首张处方</title>
    <updated>2020-12-11T19:40:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/tvoIsFQc7pExNOEIletifw</id>
    <link href="https://mp.weixin.qq.com/s/tvoIsFQc7pExNOEIletifw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ORIENT-32研究者邵国良教授：信迪利单抗联合贝伐珠单抗为晚期肝癌带来新希望，联合局部治疗有望成为治疗新模式</title>
    <updated>2020-12-11T19:40:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/hUi4ZfMcH5DeCBoOMRgzng</id>
    <link href="https://mp.weixin.qq.com/s/hUi4ZfMcH5DeCBoOMRgzng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>透过现象看本质，樊旼教授谈 PD-L1 抑制剂全新抗肿瘤机制和 SCLC 免疫治疗</title>
    <updated>2020-12-11T19:40:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/Puyp2hJb0ljOKKSCF50WJg</id>
    <link href="https://mp.weixin.qq.com/s/Puyp2hJb0ljOKKSCF50WJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“GIST 新时空”专栏 | 孙小峰教授：瑞派替尼已在海南博鳌获优先使用，新药新政策为GIST患者雪中送炭</title>
    <updated>2020-12-11T19:40:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/zuNryDgcnN_rY8VXLO7W0A</id>
    <link href="https://mp.weixin.qq.com/s/zuNryDgcnN_rY8VXLO7W0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>